| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 731,013 | 950,544 | 1,142,759 | 1,468,349 | | Cost of Revenue | 432,876 | 453,922 | 665,287 | 816,835 | | | Gross Profit | 298,137 | 496,622 | 477,472 | 651,514 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 82,050 | 163,808 | 107,343 | 129,101 | | Non Recurring | 11,218 | 233,552 | (17,297) | 140,069 | | Others | 105,113 | 241,118 | 161,905 | 184,520 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 99,756 | (141,856) | 225,521 | 197,824 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 99,756 | (141,856) | 225,521 | (32,010) | | Interest Expense | 66,671 | 66,027 | 67,078 | 26,329 | | Income Before Tax | 33,085 | (207,883) | 158,443 | (58,339) | | Income Tax Expense | 3,555 | (14,897) | 33,273 | 25,654 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 29,530 | (192,986) | 125,170 | (83,993) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 29,530 | (192,986) | 125,170 | (83,993) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $29,530 | ($192,986) | $125,170 | ($83,993) |
|
2.03% Nasdaq 
Income Statement
